ArticleOncotarget2017

Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.

Jialin Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.